# OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION

> **NIH NIH N01** · SRI INTERNATIONAL · 2023 · $11,811

## Abstract

The project is involved in the analytical assessment of bulk drug substances and clinical drug products of anti-tumor drug candidates. Physical and chemical data provided in the study reports will be submitted as part of the Investigational New Drug (IND) filing required for clinical studies of potential anti-tumor agents.

## Key facts

- **NIH application ID:** 10856892
- **Project number:** 261201200028C-P00035-9999-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** JENNIE WANG, PH.D.
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $11,811
- **Award type:** —
- **Project period:** 2012-08-01 → 2018-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10856892

## Citation

> US National Institutes of Health, RePORTER application 10856892, OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION (261201200028C-P00035-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10856892. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*